http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000513034-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
filingDate | 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2000513034-A |
titleOfInvention | Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
abstract | (57) SUMMARY OF THE INVENTION A compound of formula (I), or an N-oxide, or a pharmaceutically acceptable salt thereof, useful for inhibiting Ras function and therefore inhibiting or treating abnormal cell proliferation Alternatively, a solvate is disclosed, wherein R and R 2 are independently selected from halo; R 1 and R 3 are independently selected from the group consisting of H and halo, provided that R 1 and at least one of R 3 is H; R 4 is formula (II) or R 5; R 5 is the formula (III), (IV), (V), (VI), (VII), ( VIII), (IX), (X) or (XI); and the remaining variables are as defined herein. |
priorityDate | 1997-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.